🎉 M&A multiples are live!
Check it out!

Pfizer India Valuation Multiples

Discover revenue and EBITDA valuation multiples for Pfizer India and similar public comparables like Pharming, Julphar, and Vivoryon Therapeutics.

Pfizer India Overview

About Pfizer India

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The company has only one segment which is Pharmaceuticals and it operates in domestic market.


Founded

1950

HQ

India
Employees

1.7K+

Website

pfizerltd.co.in

Financials

LTM Revenue $261M

LTM EBITDA $79.2M

EV

$1.9B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Pfizer India Financials

Pfizer India has a last 12-month revenue of $261M and a last 12-month EBITDA of $79.2M.

In the most recent fiscal year, Pfizer India achieved revenue of $255M and an EBITDA of $95.1M.

Pfizer India expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Pfizer India valuation multiples based on analyst estimates

Pfizer India P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $282M $255M XXX XXX XXX
Gross Profit $193M $180M XXX XXX XXX
Gross Margin 69% 71% XXX XXX XXX
EBITDA $110M $95.1M XXX XXX XXX
EBITDA Margin 39% 37% XXX XXX XXX
Net Profit $71.1M $72.5M XXX XXX XXX
Net Margin 25% 28% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Pfizer India Stock Performance

As of April 15, 2025, Pfizer India's stock price is INR 4080 (or $47).

Pfizer India has current market cap of INR 187B (or $2.2B), and EV of INR 164B (or $1.9B).

See Pfizer India trading valuation data

Pfizer India Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.9B $2.2B XXX XXX XXX XXX $1.57

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Pfizer India Valuation Multiples

As of April 15, 2025, Pfizer India has market cap of $2.2B and EV of $1.9B.

Pfizer India's trades at 7.3x LTM EV/Revenue multiple, and 24.1x LTM EBITDA.

Analysts estimate Pfizer India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Pfizer India and 10K+ public comps

Pfizer India Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.9B XXX XXX XXX
EV/Revenue 7.4x XXX XXX XXX
EV/EBITDA 23.0x XXX XXX XXX
P/E 31.5x XXX XXX XXX
P/E/Growth 3.6x XXX XXX XXX
EV/FCF 27.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Pfizer India Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Pfizer India Valuation Multiples

Pfizer India's NTM/LTM revenue growth is 7%

Pfizer India's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Pfizer India's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Pfizer India's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Pfizer India and other 10K+ public comps

Pfizer India Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -10% XXX XXX XXX XXX
EBITDA Margin 32% XXX XXX XXX XXX
EBITDA Growth -13% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 39% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 7% XXX XXX XXX XXX
G&A Expenses to Revenue 5% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 37% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Pfizer India Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Pfizer India M&A and Investment Activity

Pfizer India acquired  XXX companies to date.

Last acquisition by Pfizer India was  XXXXXXXX, XXXXX XXXXX XXXXXX . Pfizer India acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Pfizer India

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Pfizer India

When was Pfizer India founded? Pfizer India was founded in 1950.
Where is Pfizer India headquartered? Pfizer India is headquartered in India.
How many employees does Pfizer India have? As of today, Pfizer India has 1.7K+ employees.
Is Pfizer India publicy listed? Yes, Pfizer India is a public company listed on NSE.
What is the stock symbol of Pfizer India? Pfizer India trades under PFIZER ticker.
When did Pfizer India go public? Pfizer India went public in 1999.
Who are competitors of Pfizer India? Similar companies to Pfizer India include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Pfizer India? Pfizer India's current market cap is $2.2B
What is the current revenue of Pfizer India? Pfizer India's last 12-month revenue is $261M.
What is the current EBITDA of Pfizer India? Pfizer India's last 12-month EBITDA is $79.2M.
What is the current EV/Revenue multiple of Pfizer India? Current revenue multiple of Pfizer India is 7.3x.
What is the current EV/EBITDA multiple of Pfizer India? Current EBITDA multiple of Pfizer India is 24.1x.
What is the current revenue growth of Pfizer India? Pfizer India revenue growth between 2023 and 2024 was -10%.
Is Pfizer India profitable? Yes, Pfizer India is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.